Uterine Fibroids

JAMA. 2024 May 7;331(17):1492-1493. doi: 10.1001/jama.2024.0447.

Authors

Erica E Marsh^{1

2}, Ganesa Wegienka³, David R Williams⁴

Affiliations

¹ Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor.
² Michigan Institute of Clinical and Health Research, University of Michigan, Ann Arbor.
³ Department of Obstetrics, Gynecology, and Reproductive Sciences, Michigan State University, East Lansing.
⁴ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

PMID: 38598205
DOI: 10.1001/jama.2024.0447

No abstract available

Plain language summary

This JAMA Insights in the Women’s Health series discusses the incidence, diagnosis, and treatment of uterine fibroids.

MeSH terms

Black or African American / statistics & numerical data
Female
Humans
Hysterectomy
Leiomyoma* / diagnosis
Leiomyoma* / epidemiology
Leiomyoma* / ethnology
Leiomyoma* / therapy
United States / epidemiology
Uterine Neoplasms* / diagnosis
Uterine Neoplasms* / epidemiology
Uterine Neoplasms* / ethnology
Uterine Neoplasms* / therapy
White / statistics & numerical data